Other

The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:  

Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.  

• Data on the outcome of ongoing fertility care.  
• Data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2. 
• Other information related to fertility outcomes.

 
The Ferring COVID-19 Investigational Grants are awarded a single time and are not renewable.

This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.

AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19.

AHRQ encourages multi-method, rapid-cycle research with the ability to: produce and disseminate initial findings (e.g. observations, lessons learned, or findings) within 6 months after award and then regularly throughout the remainder of the award period.

The COVID-19 Related Research Grants support education research projects that will contribute to understanding the rapid shifts in education in this time of crisis and change. We are especially interested in supporting two primary categories of projects. First, we are interested in supporting studies that aim to understand and disrupt the reproduction and deepening of educational inequality caused by the COVID-19 crisis. Second, we also recognize that in times of great disruption and change, there may be opportunities to remake and imagine anew forms of equitable education. Thus, we are also interested in research projects that are working to reimagine educational opportunities in these times.

As with other Spencer grant programs, this program is “field-initiated” in that proposal submissions are not for a particular research topic, discipline, design, method, or location. We will be accepting applications on a rolling basis with budgets up to $50,000 for projects ranging from one to three years. We will review applications received by May 4th, again on May 18th, and again on June 8th. Our goal for this program is to support rigorous, intellectually ambitious, and technically sound research that is relevant to the most pressing questions and compelling opportunities in education in these times.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.

To address the COVID-19 pandemic as quickly as possible, NIBIB is mobilizing and expanding the focus of POCTRN to encompass both point-of-care and more traditional laboratory-based approaches. NIBIB will consider innovations at all stages of readiness to circumvent current limitations to SARS-CoV-2 testing capacity.

RADx will provide resources to support all phases of the product development pipeline from conceptualization and design to reduction-to-practice, performance evaluation, clinical validation, and scale-up of manufacturing.

To meet the accelerated timelines, RADx has assembled a national network of expert technical, clinical, manufacturing, and regulatory advisors who will provide individualized assistance for project development and commercialization. Funding for projects selected for this program will be dependent on successfully meeting aggressive project milestones. NIBIB will provide financial and in-kind support to accelerate the entire product life-cycle, from design to market, for projects that meet milestones successfully. To ensure that innovations are available to the public as quickly as possible, NIH will leverage established partnerships with federal agencies, such as FDA, CDC, CMS, and ASPR/BARDA, as well as commercial and private entities to propel technologies developed by RADx into widespread use.

We are now accepting letters of inquiry for the 2020-2021 funding cycle of NIHCM Foundation's investigator-initiated research grant program.

This year, NIHCM is making a total of $1 million available to be allocated across our research and journalism grant programs according to the merits of the proposals received.

We are seeking research studies with strong potential to inform policy or have a positive impact on the U.S. health care system by improving efficiency, quality, access to care, preparedness or equity. 

This funding opportunity seeks to support effective coalitions that will bolster and leverage U.S.-India collaboration across a range of fields to fight COVID-19, in India and globally. Potential grantees should be able to implement a small-grants program to promote innovation in addressing COVID-19, encourage partnerships between U.S. and Indian institutions and organizations in combating COVID-19, and facilitate joint action that makes a difference against the disease. The grant will provide resources for a grantee to manage and administer small grants to stakeholders from government organizations, non-profits, think tanks, academic institutions, incubators and accelerators, in close coordination with the U.S. Mission to India. The grantee will be required to solicit proposals that contribute to and/or build upon initiatives that counter the impact of COVID-19 on Indian society, U.S.-India cooperation, and wider communities across the Indo-Pacific region. Projects may include, but are not limited to, the following:  

•  Support accurate and authentic public messaging on COVID-19 topics to combat misinformation, such as official CDC/HHS information that can be shared by civil society/NGOs in English, Hindi, and other vernacular languages.
• Help and build capacity of local NGOs to engage communities in virtual/online conversations, given current public gathering restrictions (e.g. virtual speaker program on how NGOs can support community resilience and recovery in the aftermath of a pandemic). 
• Encourage academic and R&D institutions, business associations, and NGOs to either forge new partnerships with U.S. institutions and organizations, or further strengthen and expand existing ones, for intensive collaboration in innovation, entrepreneurship, business development, and public-private partnership in order to advance new public health solutions. 
• Organize capacity-building workshops, mentoring programs, and webinars for startups and innovators working in the field of COVID-19 to maintain strong operations during this challenging time, enhance competitiveness, and better prepare the startup network in India to successfully engage with partners, investors and governments to develop effective public health solutions. Bring into the effort U.S. institutions, mentors and expertise, to help lead capacity-building exercises.    
• Other project ideas that promote U.S.-India cooperation in combating COVID-19.

Eligible Applicants:

Private institutions of higher education
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

The Emergency Medicine Foundation invites applications for its COVID-19 research grant. This supports research that will provide high-impact new knowledge to advance emergency patient care, improve response of hospitals, healthcare and emergency medical services systems, and protect emergency medicine healthcare professionals during pandemics. Topics may include the following areas:

- personal protective equipment, including design, cleaning and reuse;
- ventilator scarcity;
- telemedicine;
- laboratory testing;
- rapid screening, triage and testing;
- clinical diagnosis;
- epidemiology of disease;
- therapeutics;
- diagnostic radiology, including point of care ultrasound;
- emergency medicine workforce, including safety;
- emergency physician wellness;
- special populations, such as high-risk, homeless, non-English-speaking and transplantation patients.

This program supports projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise, aiming to help communities increase their capacity to participate across all phases of the PCOR/CER process while responding to contextual changes as a result of the COVID-19 pandemic. This is an opportunity to explore virtual/distanced methods of engagement and generate new questions and evidence needs across stakeholder groups. Grants are for 1 year and up to $150,000; proposals are due by May 22, 2020.

This is a new research funding announcement with an accelerated timeline to support innovative, high-impact studies that fit clearly within PCORI's core mission of patient-engaged and patient-centered comparative clinical effectiveness research. The objectives of this announcement are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning. Grants are up to $5 million per award; proposals are due by May 26, 2020.

Program aims to fund projects in the following areas: protecting vulnerable populations from epidemics and catastrophes; improving data collection and quality in health; understanding the effects of confinement and social distancing; early warning and preparedness; preserving the environment and our health; and learnings from COVID-19 for mitigating future related crises in climate and biodiversity. Preference will be given to projects with a local focus and potential applicability on a global scale. Applicants should be six to ten years from the awarding of their doctorate. Grants are up to 250,000 euro (roughly $275,000); applications are due by May 7, 2020.